Home | paulcarlier

Carlier Group receives $3.7 M from the NIH to develop safe drugs that combat the persistent malaria parasite at multiple life stages

Carlier Group has two openings!

Chemical Biology Post-Doctoral Associate
Medicinal Chemistry Post-Doctoral Associate

Medicinal Chemistry for Global Public Health

Malaria is a scourge in the developing world, affecting 200 million people and killing nearly 450,000 annually. To treat this infected population, new antimalarial drugs are urgently needed. As such, we are taking a two-pronged strategy to reduce malaria transmission and mortality.

(hover with cursor to stop slideshow)

Visit Prof. Carlier’s faculty page at the VT Department of Chemistry